Toronto, Canada (PRWEB) August 18, 2014
China is increasingly being recognized as the land of opportunity for the clinical research industry. Clinicaltrial.gov statistics highlight the popularity of China for clinical trials due to its aging population; a high increase in infectious diseases; a rapid rise in chronic diseases; a densely populated pool of patients and a track record of rapid patient enrolment.
Notwithstanding these positive points, China also presents challenges for the clinical research industry - a changing regulatory landscape with often protracted timelines for clinical trial approvals; new healthcare policies; import/export requirements, non-compliance to GCP (Good Clinical Practice) guidelines, not to mention cultural and language barriers.
Join keynote presenter, Ianne Loh, General Manager at Fisher Clinical Services, China, as she discusses these opportunities and challenges and provides tips on how to achieve success in running clinical trials in China, including:
- Keeping up-to-date on regulatory requirements
- Appreciating clinical trial approval timelines
- Understanding the true cost of shipments
- Ensuring importation documentation is in order
- Applying best practices across the supply chain
- Managing the entire supply chain from Sponsor to investigator site
For more information or to register for this webinar, visit: China – Land of Opportunities & Challenges for the Clinical Research Industry
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
Tel: +1 (416) 977-6555 ext 352